Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Apr 15;99(8):1936–1946. doi: 10.1172/JCI119361

Roles of interferon-gamma and interleukin-4 in murine lupus.

S L Peng 1, J Moslehi 1, J Craft 1
PMCID: PMC508018  PMID: 9109438

Abstract

The systemic autoimmune syndrome of MRL/Mp-lpr/lpr (MRL/lpr) mice consists of severe pan-isotype hypergammaglobulinemia, autoantibody production, lymphadenopathy, and immune complex-associated end-organ disease. Its pathogenesis has been largely attributed to helper alphabeta T cells that may require critical cytokines to propagate pathogenic autoantibody production. To investigate the roles of prototypical Th1 and Th2 cytokines in the pathogenesis of murine lupus, IFN-gamma -/- and IL-4 -/- lupus-prone mice were generated by backcrossing cytokine knockout animals against MRL/lpr breeders. IFN-gamma -/- animals produced significantly reduced titers of IgG2a and IgG2b serum immunoglobulins as well as autoantibodies, but maintained comparable levels of IgG1 and IgE in comparison to cytokine-intact controls; in contrast, IL-4 -/- animals produced significantly less IgG1 and IgE serum immunoglobulins, but maintained comparable levels of IgG2a and IgG2b as well as autoantibodies in comparison to controls. Both IFN-gamma -/- and IL-4 -/- mice, however, developed significantly reduced lymphadenopathy and end-organ disease. These results suggest that IFN-gamma and IL-4 play opposing but dispensable roles in the development of lupus-associated hypergammaglobulinemia and autoantibody production; however, they both play prominent roles in the pathogenesis of murine lupus-associated tissue injury, as well as in lpr-induced lymphadenopathy.

Full Text

The Full Text of this article is available as a PDF (641.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abed N. S., Chace J. H., Cowdery J. S. T cell-independent and T cell-dependent B cell activation increases IFN-gamma R expression and renders B cells sensitive to IFN-gamma-mediated inhibition. J Immunol. 1994 Oct 15;153(8):3369–3377. [PubMed] [Google Scholar]
  2. Adachi M., Watanabe-Fukunaga R., Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1756–1760. doi: 10.1073/pnas.90.5.1756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., Murphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 Nov 1;148(5):1198–1215. doi: 10.1084/jem.148.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burlingame R. W., Rubin R. L., Balderas R. S., Theofilopoulos A. N. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest. 1993 Apr;91(4):1687–1696. doi: 10.1172/JCI116378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chu J. L., Drappa J., Parnassa A., Elkon K. B. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med. 1993 Aug 1;178(2):723–730. doi: 10.1084/jem.178.2.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cohen P. L., Eisenberg R. A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 1991;9:243–269. doi: 10.1146/annurev.iy.09.040191.001331. [DOI] [PubMed] [Google Scholar]
  7. Dalton D. K., Pitts-Meek S., Keshav S., Figari I. S., Bradley A., Stewart T. A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993 Mar 19;259(5102):1739–1742. doi: 10.1126/science.8456300. [DOI] [PubMed] [Google Scholar]
  8. Eisenberg R. A., Craven S. Y., Fisher C. L., Morris S. C., Rapoport R., Pisetsky D. S., Cohen P. L. The genetics of autoantibody production in MRL/lpr lupus mice. Clin Exp Rheumatol. 1989 Sep-Oct;7 (Suppl 3):S35–S40. [PubMed] [Google Scholar]
  9. Eisenberg R. A., Craven S. Y., Warren R. W., Cohen P. L. Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J Clin Invest. 1987 Sep;80(3):691–697. doi: 10.1172/JCI113123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Eisenberg R. A., Tan E. M., Dixon F. J. Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med. 1978 Feb 1;147(2):582–587. doi: 10.1084/jem.147.2.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eisenberg R. A., Winfield J. B., Cohen P. L. Subclass restriction of anti-Sm antibodies in MRL mice. J Immunol. 1982 Nov;129(5):2146–2149. [PubMed] [Google Scholar]
  12. Fisher G. H., Rosenberg F. J., Straus S. E., Dale J. K., Middleton L. A., Lin A. Y., Strober W., Lenardo M. J., Puck J. M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995 Jun 16;81(6):935–946. doi: 10.1016/0092-8674(95)90013-6. [DOI] [PubMed] [Google Scholar]
  13. Fong T. A., Mosmann T. R. The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones. J Immunol. 1989 Nov 1;143(9):2887–2893. [PubMed] [Google Scholar]
  14. Hewicker M., Trautwein G. Glomerular lesions in MRL mice. A light and immunofluorescence microscopic study. Zentralbl Veterinarmed B. 1986 Dec;33(10):727–739. doi: 10.1111/j.1439-0450.1986.tb00093.x. [DOI] [PubMed] [Google Scholar]
  15. Huang F. P., Feng G. J., Lindop G., Stott D. I., Liew F. Y. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J Exp Med. 1996 Apr 1;183(4):1447–1459. doi: 10.1084/jem.183.4.1447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R. M., Aguet M. Immune response in mice that lack the interferon-gamma receptor. Science. 1993 Mar 19;259(5102):1742–1745. doi: 10.1126/science.8456301. [DOI] [PubMed] [Google Scholar]
  17. Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med. 1994 Jan 1;179(1):305–310. doi: 10.1084/jem.179.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Issekutz T. B., Stoltz J. M., van der Meide P. The recruitment of lymphocytes into the skin by T cell lymphokines: the role of gamma-interferon. Clin Exp Immunol. 1988 Jul;73(1):70–75. [PMC free article] [PubMed] [Google Scholar]
  19. Izui S., Kelley V. E., Masuda K., Yoshida H., Roths J. B., Murphy E. D. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol. 1984 Jul;133(1):227–233. [PubMed] [Google Scholar]
  20. Jacob C. O., van der Meide P. H., McDevitt H. O. In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J Exp Med. 1987 Sep 1;166(3):798–803. doi: 10.1084/jem.166.3.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jevnikar A. M., Grusby M. J., Glimcher L. H. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med. 1994 Apr 1;179(4):1137–1143. doi: 10.1084/jem.179.4.1137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jonsson R., Tarkowski A., Bäckman K., Holmdahl R., Klareskog L. Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology. 1987 Apr;60(4):611–616. [PMC free article] [PubMed] [Google Scholar]
  23. Katagiri T., Cohen P. L., Eisenberg R. A. The lpr gene causes an intrinsic T cell abnormality that is required for hyperproliferation. J Exp Med. 1988 Mar 1;167(3):741–751. doi: 10.1084/jem.167.3.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Klinman D. M., Steinberg A. D. Inquiry into murine and human lupus. Immunol Rev. 1995 Apr;144:157–193. doi: 10.1111/j.1600-065x.1995.tb00069.x. [DOI] [PubMed] [Google Scholar]
  25. Kobayashi S., Hirano T., Kakinuma M., Uede T. Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice. Biochem Biophys Res Commun. 1993 Mar 15;191(2):617–624. doi: 10.1006/bbrc.1993.1262. [DOI] [PubMed] [Google Scholar]
  26. Koh D. R., Ho A., Rahemtulla A., Fung-Leung W. P., Griesser H., Mak T. W. Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur J Immunol. 1995 Sep;25(9):2558–2562. doi: 10.1002/eji.1830250923. [DOI] [PubMed] [Google Scholar]
  27. Kühn R., Rajewsky K., Müller W. Generation and analysis of interleukin-4 deficient mice. Science. 1991 Nov 1;254(5032):707–710. doi: 10.1126/science.1948049. [DOI] [PubMed] [Google Scholar]
  28. Lo D. Animal models of human disease. Transgenic and knockout models of autoimmunity: Building a better disease? Clin Immunol Immunopathol. 1996 May;79(2):96–104. doi: 10.1006/clin.1996.0056. [DOI] [PubMed] [Google Scholar]
  29. Miletic V. D., Frank M. M. Complement-immunoglobulin interactions. Curr Opin Immunol. 1995 Feb;7(1):41–47. doi: 10.1016/0952-7915(95)80027-1. [DOI] [PubMed] [Google Scholar]
  30. Morse H. C., 3rd, Davidson W. F., Yetter R. A., Murphy E. D., Roths J. B., Coffman R. L. Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset. J Immunol. 1982 Dec;129(6):2612–2615. [PubMed] [Google Scholar]
  31. Nemazee D., Guiet C., Buerki K., Marshak-Rothstein A. B lymphocytes from the autoimmune-prone mouse strain MLR/lpr manifest an intrinsic defect in tetraparental MRL/lpr in equilibrium DBA/2 chimeras. J Immunol. 1991 Oct 15;147(8):2536–2539. [PubMed] [Google Scholar]
  32. Nicoletti F., Meroni P., Di Marco R., Barcellini W., Borghi M. O., Gariglio M., Mattina A., Grasso S., Landolfo S. In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse. Immunopharmacology. 1992 Jul-Aug;24(1):11–16. doi: 10.1016/0162-3109(92)90064-j. [DOI] [PubMed] [Google Scholar]
  33. Ozmen L., Roman D., Fountoulakis M., Schmid G., Ryffel B., Garotta G. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis. Eur J Immunol. 1995 Jan;25(1):6–12. doi: 10.1002/eji.1830250103. [DOI] [PubMed] [Google Scholar]
  34. Peng S. L., Madaio M. P., Hayday A. C., Craft J. Propagation and regulation of systemic autoimmunity by gammadelta T cells. J Immunol. 1996 Dec 15;157(12):5689–5698. [PubMed] [Google Scholar]
  35. Peng S. L., Madaio M. P., Hughes D. P., Crispe I. N., Owen M. J., Wen L., Hayday A. C., Craft J. Murine lupus in the absence of alpha beta T cells. J Immunol. 1996 May 15;156(10):4041–4049. [PubMed] [Google Scholar]
  36. Perkins D. L., Glaser R. M., Mahon C. A., Michaelson J., Marshak-Rothstein A. Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras. J Immunol. 1990 Jul 15;145(2):549–555. [PubMed] [Google Scholar]
  37. Prud'homme G. J., Balderas R. S., Dixon F. J., Theofilopoulos A. N. B cell dependence on and response to accessory signals in murine lupus strains. J Exp Med. 1983 Jun 1;157(6):1815–1827. doi: 10.1084/jem.157.6.1815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Prud'homme G. J., Kono D. H., Theofilopoulos A. N. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice. Mol Immunol. 1995 May;32(7):495–503. doi: 10.1016/0161-5890(95)00024-9. [DOI] [PubMed] [Google Scholar]
  39. Renno T., Hahne M., Tschopp J., MacDonald H. R. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J Exp Med. 1996 Feb 1;183(2):431–437. doi: 10.1084/jem.183.2.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Santoro T. J., Portanova J. P., Kotzin B. L. The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J Exp Med. 1988 May 1;167(5):1713–1718. doi: 10.1084/jem.167.5.1713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Schorlemmer H. U., Dickneite G., Kanzy E. J., Enssle K. H. Modulation of the immunoglobulin dysregulation in GvH- and SLE-like diseases by the murine IL-4 receptor (IL-4-R). Inflamm Res. 1995 Aug;44 (Suppl 2):S194–S196. doi: 10.1007/BF01778328. [DOI] [PubMed] [Google Scholar]
  42. Shlomchik M. J., Madaio M. P., Ni D., Trounstein M., Huszar D. The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med. 1994 Oct 1;180(4):1295–1306. doi: 10.1084/jem.180.4.1295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Singer G. G., Abbas A. K. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1994 Aug;1(5):365–371. doi: 10.1016/1074-7613(94)90067-1. [DOI] [PubMed] [Google Scholar]
  44. Sobel E. S., Cohen P. L., Eisenberg R. A. lpr T cells are necessary for autoantibody production in lpr mice. J Immunol. 1993 May 1;150(9):4160–4167. [PubMed] [Google Scholar]
  45. Sobel E. S., Katagiri T., Katagiri K., Morris S. C., Cohen P. L., Eisenberg R. A. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J Exp Med. 1991 Jun 1;173(6):1441–1449. doi: 10.1084/jem.173.6.1441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Steinberg E. B., Santoro T. J., Chused T. M., Smathers P. A., Steinberg A. D. Studies of congenic MRL-Ipr/Ipr.xid mice. J Immunol. 1983 Dec;131(6):2789–2795. [PubMed] [Google Scholar]
  47. Takahashi S., Fossati L., Iwamoto M., Merino R., Motta R., Kobayakawa T., Izui S. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest. 1996 Apr 1;97(7):1597–1604. doi: 10.1172/JCI118584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tsai C. Y., Wu T. H., Huang S. F., Sun K. H., Hsieh S. C., Han S. H., Yu H. S., Yu C. L. Abnormal splenic and thymic IL-4 and TNF-alpha expression in MRL-lpr/lpr mice. Scand J Immunol. 1995 Feb;41(2):157–163. doi: 10.1111/j.1365-3083.1995.tb03548.x. [DOI] [PubMed] [Google Scholar]
  49. Umland S., Lee R., Howard M., Martens C. Expression of lymphokine genes in splenic lymphocytes of autoimmune mice. Mol Immunol. 1989 Jul;26(7):649–656. doi: 10.1016/0161-5890(89)90047-3. [DOI] [PubMed] [Google Scholar]
  50. Van Parijs L., Ibraghimov A., Abbas A. K. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity. 1996 Mar;4(3):321–328. doi: 10.1016/s1074-7613(00)80440-9. [DOI] [PubMed] [Google Scholar]
  51. Vlahakos D. V., Foster M. H., Adams S., Katz M., Ucci A. A., Barrett K. J., Datta S. K., Madaio M. P. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int. 1992 Jun;41(6):1690–1700. doi: 10.1038/ki.1992.242. [DOI] [PubMed] [Google Scholar]
  52. Vlahakos D., Foster M. H., Ucci A. A., Barrett K. J., Datta S. K., Madaio M. P. Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J Am Soc Nephrol. 1992 Feb;2(8):1345–1354. doi: 10.1681/ASN.V281345. [DOI] [PubMed] [Google Scholar]
  53. Watanabe-Fukunaga R., Brannan C. I., Copeland N. G., Jenkins N. A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992 Mar 26;356(6367):314–317. doi: 10.1038/356314a0. [DOI] [PubMed] [Google Scholar]
  54. Wu J., Zhou T., He J., Mountz J. D. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med. 1993 Aug 1;178(2):461–468. doi: 10.1084/jem.178.2.461. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES